The present invention provides a new crystalline form of bimatoprost, designated as crystalline form II. This new crystalline form is the most stable form known to date of bimatoprost.

The invention also provides a new form of the compound 4-[4-(4-fluorophenoxy)benzenesulfonyl amino]-tetrahydropyran-4 carboxylic acid hydroxyamide which is referred to as Form B.

Novel methods for the preparation of sertraline hydrochloride Forms II, III, V, VI, VII, VIII, IX and X. Novel Form II is also disclosed.

A new design of the hub (4) should reduce such stresses.

The present invention relates to a novel crystalline form of tegaserod hydrochloride and to processes for preparing said form.

This invention relates also to a new crystalline form of perindopril and to a new amorphous form of perindopril.

The shape of the new 3D geometric form corresponds to the input gesture.

This invention discloses a novel stable crystal form of imatinib mesylate, designated by us as α2 Form, which is stable at room temperature and even at higher temperatures upto 120 °C and accelerated stress conditions and, freely soluble in water.

The subject matter of the invention is a novel form of mascara in the powder form.

A new form of property requires a new form of remuneration.

A new form of property requires a new form of renumeration.

A new form of property requires a new form of remuneration.

The novel crystalline forms are designated as Form I, Form II and the amorphous ibandronate monosodium monohydrate as Form III.

There is disclosed a novel form of avermectin compounds wherein the avermectin compounds are crystallized as alcohol solvates to greatly enhance stability of the avermectin drug during long-term storage.

The invention relates to a novel form of titanium oxide.